Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
about
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidateHuman papillomavirus infection is inhibited by host autophagy in primary human keratinocytesCurrent understanding of the mechanism of HPV infectionPapillomavirus Infectious Pathways: A Comparison of SystemsMultipurpose prevention technologies: the future of HIV and STI protectionThe cytoskeleton in papillomavirus infectionHuman papillomavirus induced transformation in cervical and head and neck cancersRole of heparan sulfate in sexually transmitted infectionsConcepts of papillomavirus entry into host cellsLarge scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomavirusesEntry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosisStructural Basis of Oligosaccharide Receptor Recognition by Human PapillomavirusMolecular mechanisms of HPV mediated neoplastic progressionVLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirusRequirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor XTarget cell cyclophilins facilitate human papillomavirus type 16 infectionDifferential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV typesDirect binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infectionA pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2Genome-wide identification of susceptibility alleles for viral infections through a population genetics approachCommon genetic variants and risk for HPV persistence and progression to cervical cancer.Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7Potential anti-HPV and related cancer agents from marine resources: an overview.Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar.Papillomavirus prophylactic vaccines: established successes, new approaches.Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosisIdentification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.Cellular receptor binding and entry of human papillomavirus.Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions.Mechanisms of cell entry by human papillomaviruses: an overview.Pseudomonas aeruginosa-mediated damage requires distinct receptors at the apical and basolateral surfaces of the polarized epithelium.The role of furin in papillomavirus infection.HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing.Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.Usage of heparan sulfate, integrins, and FAK in HPV16 infection.Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.Glycosaminoglycan distribution in the rat uterine cervix during the estrous cycle.Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.
P2860
Q24288709-E2FC3C6E-9BAB-4D72-AB3C-429D23B10185Q24307707-2B00641D-3929-430A-8894-0BBBD35B6437Q24616134-3556C939-9E04-428F-895C-C6C181535561Q26801497-FCDE6E00-899B-450C-B1D1-A45133F94B22Q26827796-8C6D3B5E-F824-4BD9-A66B-26EA811F9C9AQ26861667-D0E22DE0-0225-4BE8-AF7E-743EC71B5DD3Q27003141-AAB670BF-E25C-445D-B54C-BFD877A22CD7Q27023959-3C9ADC66-24D4-498E-9391-C20C2E5AEAEDQ27026900-D27F08B0-7C6A-40DB-A5B5-D88D5126D21BQ27325402-447CA750-18E8-481E-9146-FCA56A379DB9Q27346336-51B15DD4-148E-40FF-A6D8-EB077CAC7454Q27666101-6499A836-26EC-4DF7-B6FC-9439B99754A5Q28070323-9C256A8E-3755-4704-BA8F-55A98F1DA45CQ28280059-EDDF2677-BCAB-41DB-9CAF-8C6F5F716D98Q28475714-9DEE1BC4-5AF9-4B00-A34D-0F192C50976EQ28475787-ADCEE705-54CB-4511-814F-71439D1CD5CAQ28534531-20977132-DBAB-4E74-84D7-4C7C6701E4A7Q28543528-62EF948D-1E2C-42B4-909B-7219866879C9Q28741364-8FAB4B38-0E76-4956-85C3-6B5E36F53B16Q28748816-793CC3D6-2CF5-42BC-AB54-06B31F77A76BQ33525051-63B326C4-362C-4D5C-843A-C8BB89D67091Q33569555-F2C3CE20-E0DA-41F6-B259-22B1FB40843EQ33575647-EEB2526C-091E-4C93-8083-A06D013503DFQ33591582-896CD02C-BB52-4A54-A65C-D547E74BD430Q33599023-6EAB30DA-A42B-4257-81CB-E001716510BCQ33614425-02F1F247-E766-4076-BF16-D5FD879F9AE1Q33626389-641ACF41-FA2A-46A7-9082-B25FD8904DD4Q33636333-73076A79-1FAC-44E2-BDB9-738065047C13Q33647192-1047F620-42D9-4180-8AAD-AF973950A52AQ33652425-50CF58B3-27FC-4E96-899E-C2EF3F109D0BQ33663169-F1E530D7-F987-488B-BEE6-897AA6BAE482Q33675996-6F6C61F6-B7F5-40AA-9EBE-74B7757368DBQ33693739-BFCF099A-83AE-4063-B9B3-5F1E63A18028Q33714325-5990B51F-7394-4563-B745-D80B2434F360Q33826064-E414B895-CD1A-4D19-8054-1D09FA0D2B4DQ33905761-7826D1AF-87CE-45AD-8052-8AF509E75D84Q33923898-FB7635AC-4DC5-4B2B-8642-4C903E0EC65DQ33987448-01C5A73F-0967-40D0-9286-FBC90075D950Q34023477-60764519-5593-4B28-8846-9C001D791646Q34075698-00C0CF8C-9DCE-41F7-8B23-E610DF0B4BB9
P2860
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of heparan sulfate in att ...... tract by human papillomavirus.
@en
Role of heparan sulfate in att ...... tract by human papillomavirus.
@nl
type
label
Role of heparan sulfate in att ...... tract by human papillomavirus.
@en
Role of heparan sulfate in att ...... tract by human papillomavirus.
@nl
prefLabel
Role of heparan sulfate in att ...... tract by human papillomavirus.
@en
Role of heparan sulfate in att ...... tract by human papillomavirus.
@nl
P2093
P2860
P356
P1433
P1476
Role of heparan sulfate in att ...... tract by human papillomavirus.
@en
P2093
Douglas R Lowy
Jeffrey N Roberts
John T Schiller
Katherine M Johnson
Patricia M Day
Rhonda C Kines
P2860
P304
P356
10.1128/JVI.02190-08
P407
P577
2008-12-10T00:00:00Z